These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17204946)

  • 1. Hepatitis B virus: something old, something new.
    Dumas L; Vergani D; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):14-7. PubMed ID: 17204946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
    Price N; Boxall EH
    J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B.
    Janssen HL; van Zonneveld M; Schalm SW
    N Engl J Med; 2004 Jun; 350(26):2719-20. PubMed ID: 15215493
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving approaches to the treatment of chronic hepatitis B virus infection in children.
    Kerkar N; Shneider BL
    J Clin Gastroenterol; 2005 Jan; 39(1):7-9. PubMed ID: 15599202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis B: when to use lamivudine?].
    Renner EL
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):39-41. PubMed ID: 10670046
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B in children.
    Jonas MM
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S56-60. PubMed ID: 16819403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of interferon-mediated antiviral immunity by hepatitis B virus: an overview of research progress.
    Guo P
    Scand J Immunol; 2013 Sep; 78(3):230-7. PubMed ID: 23790137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
    Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of viral-specific immune responses on the outcome of chronic hepatitis B (HBV) infection in children: new insights into immunopathology.
    Carey I; Vergani D
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):15-8. PubMed ID: 17592359
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
    Arcaini L; Merli M; Rattotti S; Bruno R; Vercelli A; Lucioni M; Riboni R; Paulli M
    J Clin Oncol; 2011 Jun; 29(18):e543-5. PubMed ID: 21482990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH; Deng X; Chen XC; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
    Cheong JY; Cho SW; Yoo JH; Hong SP; Kim SO; Yoo WD; Kim JH
    Hepatogastroenterology; 2008; 55(84):1029-33. PubMed ID: 18705323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of HBeAg-positive patients with nucleos/tide analogues.
    Coffin CS; Lee SS
    Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
    Jonas MM; Little NR; Gardner SD;
    J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.